Top 4 Stocks In The Drugs-Generic Industry With The Highest ROE

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Akorn Inc (NASDAQ: AKRX) is 34.35%. AKRX's profit margin for the same period is 26.40%.

The trailing-twelve-month return on equity at Hi-Tech Pharmacal Co Inc (NASDAQ: HITK) is 24.05%. HITK's PEG ratio is 0.66.

The trailing-twelve-month return on equity at Mylan Inc (NASDAQ: MYL) is 10.03%. MYL's revenue for the same period is $5.61 billion.

The trailing-twelve-month return on equity at Watson Pharmaceuticals Inc (NYSE: WPI) is 4.90%. WPI's operating margin for the same period is 11.34%.

Trading Ideas.